[1]
“Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia”, Colomb Med, vol. 41, no. 4, pp. 315–322, Dec. 2010, doi: 10.25100/cm.v41i4.722.